Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $7.6300 (1.6%) ($7.6300 - $7.6300) on Wed. Feb. 3, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.63% (three month average) | RSI | 30 | Latest Price | $7.6300(1.6%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -1.4% a day on average for past five trading days. | Weekly Trend | AUTL declines -8.3% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) LIT(13%) SKYY(13%) XBI(13%) BNDX(12%) IBB(12%) | Factors Impacting AUTL price | AUTL will decline at least -2.315% in a week (0% probabilities). USO(-7%) TBT(-7%) VIXM(-6%) IGOV(-6%) UNG(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.315% (StdDev 4.63%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-5.66(-174.18%) | Inflection Point | Yes | Resistance Level | $8.48 | 5 Day Moving Average | $7.52(1.46%) | 10 Day Moving Average | $8.03(-4.98%) | 20 Day Moving Average | $8.48(-10.02%) | To recent high | -36.4% | To recent low | 4.1% | Market Cap | $399m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |